Salfarm: Polaris Partners with Salfarm to Lead Nordic Animal Health Market
Deal News | Nov 22, 2024 | Polaris Flexible Capital
Polaris Private Equity has announced its acquisition of a majority stake in Salfarm, a Danish pharmaceutical company specializing in animal health products. Salfarm, established in 1979, has demonstrated notable growth within the Nordic animal pharmaceutical market. Subsequent to this acquisition, Salfarm and Polaris together concluded the purchase of FaunaPharma, a Finnish veterinary pharmaceutical player, thereby strengthening Salfarm's presence in Finland. The strategic ambition is to expand Salfarm's influence beyond Denmark and grow as a prominent player in the Nordic region. With this acquisition, Polaris aims to leverage Salfarm’s existing reputation and network in the industry to fuel further expansion in the Nordics. This initial acquisition of FaunaPharma marks the beginning of this ambitious expansion strategy.
Sectors
- Animal Pharmaceuticals
- Private Equity
Geography
- Denmark – Salfarm is headquartered in Denmark and is a major player in the Danish animal pharmaceutical market.
- Finland – The acquisition of FaunaPharma expands Salfarm’s presence into Finland.
- Nordic Region – The article discusses the expansion strategy throughout the Nordic animal health market.
Industry
- Animal Pharmaceuticals – The industry focuses on the development and distribution of pharmaceuticals and health products for animals. This is relevant as both Salfarm and FaunaPharma operate within this sector.
- Private Equity – Involves investments and acquisition of equity ownership in companies, relevant as Polaris Private Equity is a key player in the acquisition.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Polaris Private Equity | Buyer | Company | A private equity firm that acquired a majority stake in Salfarm. |
| Salfarm | Target Company | Company | A Danish animal pharmaceutical company targeted by Polaris for acquisition. |
| FaunaPharma | Acquired Company | Company | A Finnish veterinary pharmaceutical company acquired by Salfarm with Polaris’s support. |